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Intracranial pressure and brain compliance
in traumatic brain injury
Elevated intracranial pressure (ICP) has been associated
with increased mortality in patients with severe traumatic
brain injury (TBI). More than 20 years ago, Marmarou
[1], while analysing the data from the traumatic coma
data bank (TCDB), recognized that the proportion of
hourly ICP readings greater than 20 mmHg was funda-
mental in explaining long-term outcome in TBI victims.
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Since that moment, the cutoff point of 20 mmHg has been
selected as most indicative in neurotraumatology. Not
only times spent over the threshold, but also the responses
to the therapy are crucial. Following this concept,
Treggiari [2] systematically reviewed the literature to
estimate the association between ICP patterns and out-
come. Confirming Marmarou’s observations, raised ICP,
i.e. an ICP [20 mmHg, was associated with an increased
probability of death. Moreover, if ICP was raised but
treatable, this condition was associated with a threefold to
fourfold increase in the probability of death or poor
neurological outcome. If ICP was raised and refractory,
this was associated with a dramatic increase in the relative
risk of death (OR 114.3). Therefore, refractory ICP and
response to ICP treatment could be better predictors of
neurological outcome than absolute ICP values.
Badri et al. [3] examined whether raised ICP is
independently associated with mortality, functional sta-
tus and neuropsychological functioning in adult TBI
patients. Data from 499 participants in a randomized
trial, comparing intravenous magnesium sulfate to pla-
cebo in moderate to severe TBI patients, were
secondarily analysed. The primary endpoints were
mortality and a composite measure of functional sta-
tus and neuropsychological function, evaluated as
memory, speed of information processing, and execu-
tive function over a 6-month period. Moreover, the
authors examined different summarizations of ICP
during the first 48 h, to test the hypothesis that ICP
values or patterns are independently associated with
mortality and neurobehavioral function in patients with
TBI. ICP recordings were evaluated using different a
priori specified measures as average ICP, defined as
area under the curve (AUC) of the first 48 h of ICP
measurements divided by the time monitored corre-
sponding to time-weighted ICP average; time-weighted
average ICP [20 mmHg; baseline ICP; maximum ICP
recorded in 48 h; and last ICP at the end of the 48 h
monitoring period. The area under the curve of the ICP
profile (average ICP) during the first 48 h of monitoring
was the main predictor of interest. The overall 6-month
mortality was 18 %. The adjusted odds ratio of mor-
tality comparing 10-mmHg increases in average ICP
was 3.12 (95 % confidence interval [CI] 1.79, 5.44;
p \ 0.01). Overall, higher average ICP was associated
with decreased functional status and neuropsychological
functioning (p \ 0.01). Importantly, among survivors,
increasing average ICP wasn’t independently associated
with inferior performance on neuropsychological test-
ing. The conclusions of this study suggest that raised
average ICP during the first 48 h of admission does not
necessarily have adverse effects on the neuropsycho-
logical and functional abilities of TBI survivors, as the
association of ICP and outcome was mostly contributed
by the excess mortality. The lack of association
between neuropsychological function and early ICP
values among survivors has potential implications for
treatment. It is encouraging to observe that patients
with different ICP profiles in the ICU can achieve
comparable neurological outcome at 6 months post-
injury, provided they survive to achieve this milestone.
These findings can have implications in clinical deci-
sion-making and prognostic considerations among TBI
survivors.
Since the final part of the last century, neuroscientist
and neurointensivists, being aware of the negative effect
of high ICP, tried to anticipate its rise, studying the so-
called ‘brain compliance’, the sum of compliances of
the brain, of the venous and arterial compartment and
of CSF. Therefore, the resulting overall brain compli-
ance is a non-linear function of many compartmental
pressures. Due to the complexity of this picture and the
difficulties in its interpretation, and the advent of con-
tinuous ICP monitoring, compliance studies were
utilized less and less in neurocritical care. Howells
et al. [4] compared different measures of cerebrospinal
compensatory reserve, i.e. ICP amplitude, ICP slope,
and the correlation of ICP amplitude and ICP mean
(RAP index), in a cohort of 84 patients with traumatic
brain injury both before and after second tier medical
and surgical therapies. Mean values of the three mea-
sures were calculated in the 2-h periods before and
after surgery, and in the 12-h periods preceding and
during periods of thiopental coma. ICP amplitude was
significantly correlated with Glasgow Motor Score, and
also with age for patients 35 years old and older. The
correlations of ICP slope and the RAP index
with Glasgow Motor Score and with age were not
significant. All three metrics indicated significant
improvements in compliance following surgery and
during thiopental coma. The strong point of this study
is that it characterizes the response to medication: the
described measures of ICP waveform are dependent on
the type of surgery and thiopental administration. None
of the metrics were significantly correlated with out-
come, possibly due to confounding effects of treatment.
The results regarding thiopental coma demonstrate
that all of these compliance metrics convey important
information not evident from mean ICP alone. ICP
amplitude performed was the only metric that was
significantly correlated with severity of injury, indicat-
ing a declining compliance in older patients. It also
has the advantages of simplicity and of being a
very salient characteristic of the waveform. The
quest for finding an anticipatory sign of high ICP
continues.
TBI in ovulating females results in favorable neuro-
logical outcomes compared to males with similar insults
[5]. Zlotnik et al. [6] observed that the administration of
estrogen in male rats with TBI decreased blood glutamate
levels and improved neurological application, thus pro-
viding neuroprotection.
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Anaemia in TBI
Anaemia is one of the most common medical complica-
tions in neurocritically ill patients. In this cohort, lower
haemoglobin concentrations are consistently associated
with worse physiologic parameters and clinical outcomes.
Nowadays, based on the results of clinical trials, trans-
fusion practices in ICU have generally become more
restrictive. However, because reduced oxygen delivery
contributes to ‘secondary’ cerebral injury, anaemia may
not be as well tolerated among neurocritical care patients.
There have been no randomized controlled trials that have
adequately evaluated optimal transfusion thresholds
among brain-injured patients [7].
Along with increased flow produced by increased
heart rate and contractility, thereby augmenting CO, and
lower blood viscosity, anaemia also induces cerebral
vasodilatation. As anaemia worsens, the resultant
increases in cerebral blood flow and the increased oxygen
extraction fraction eventually become insufficient to
overcome the reduced CaO2 produced by low haemo-
globin (Hgb) concentrations. The point at which this
threshold is reached is unclear, and probably varies
between patients. Physiological information, such as the
local availability of oxygen in the brain tissue, could help
the clinicians in identifying a tailored transfusion
threshold for a specific patient.
For answering to this conundrum, Oddo et al. [8]
investigated the relationship between Hgb and brain tissue
oxygen tension (PbtO2) after severe TBI and examined its
impact on outcome. He performed a retrospective analysis
on a cohort of severe TBI patients. Four hundred seventy-
four simultaneous Hgb and PbtO2 recordings from 80
patients were analysed. Hgb B 9 g/dl was associated with
lower PbtO2. Anaemia with simultaneous tissue hypoxia,
i.e. a PbtO2 \ 20 mmHg, but not anaemia alone,
increased the risk of unfavourable outcome (odds ratio
6.24 (95 % CI 1.61, 24.22), p = 0.008), after controlling
for other confounders.
These findings suggest that anaemia-associated reduced
PbtO2 may aggravate TBI prognosis, and support the con-
cept that PbtO2 or other monitoring systems of the oxygen
availability in the brain may be a helpful physiologic target
for the tailoring Hgb levels after severe head injury.
Sedation in neurocritical care patients
Recent evidence suggests that sedative drugs use in
general intensive care unit patients should be minimized
[9]. However, this does not apply to acute brain injury
patients, because in this cohort, sedation, along with
general targets, has additional aims: neuroprotective
properties and improve intracranial pressure control [10].
The research of neuroprotection using sedation is still an
open question. Recently, a large number of animal studies
investigated the potential neuroprotective effect of vola-
tile anesthetic agents. In vivo, it has been demonstrated
that preconditioning with isoflurane improves long-term
neurologic outcome after hypoxic-ischemic brain injury
[11]. These seminal animal research studies, even if
attractive for their potential benefit for ischemic damage,
have not been translated into clinical studies, mainly
because the use of a volatile agent carries the potential
risk of vasodilatation producing an increase in cerebral
blood flow (CBF) and, consequently, a rise in ICP. For
this reason, use of these drugs has been traditionally
considered unsafe in acute brain damaged patients, and
confined outside neuro ICUs. Until recently, surpassing
these boundaries seemed imprudent. Continuous ICP and
CBF monitoring and the delineation of safety thresholds
have allowed for securely setting sail for this adventure.
Bo¨sel et al. [12] investigated the effects of 3 days of
volatile isoflurane sedation on cerebral oxygenation, cir-
culation and pressure in ischemic and haemorrhagic
strokes. They observed a clinically irrelevant increase in
ICP. Mean arterial pressure (MAP) and cerebral perfusion
pressure (CPP) were decreased, particularly in patients
who were previously on midazolam. They concluded that
it is possible to reach satisfactory sedation by applying
volatile isoflurane for the long-term without causing a
relevant raise in ICP if baseline ICP values are low or
only moderately elevated and if arterial blood pressure
and PaCO2 are kept stable.
Nevertheless, an increase in ICP should be considered
and monitored when applying this sedative agent, and we
agree with the author’s recommendation that multimodal
neuromonitoring is mandatory when applying volatile
sedation. However, the results are consistent with other
recently published experience [13]. These data need to be
confirmed in larger prospective studies, and the possibility to
transfer the experimental evidence to the bedside is fasci-
nating, mainly in patients with a therapeutic window of
preconditioning, such as subarachnoid haemorrhage (SAH)
victims. A large fraction of SAH patients develop a delayed,
days after the initial bleeding, neurological deficit even when
the aneurysm is successfully secured. This seems to be linked
to vasospasm and the molecular cascades of early brain
injury. An early therapeutic intervention, such as sedation
with volatile anesthetics, has the potential advantage at
stopping these molecular cascades and may reduce the long-
term deficits. Nevertheless, this experience has opened a
new, hitherto unexplored, scenario.
Delirium
Systematic monitoring of sedation, pain and delirium in
the ICU is important in delivering adequate patient care.
While the use of systematic monitoring tools is widely
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agreed upon, these are infrequently applied to daily ICU
care. Radtke et al. [14] compared the effectiveness of two
different training strategies, i.e. training according to the
local standard versus modified extended method, on the
implementation rate of scoring instruments for sedation,
pain and delirium in the ICU. The modified extended
training included establishing a local support team help-
ing to resolve immediate problems.
In this experimental cohort study, the frequencies of
scoring ICUs before and after training and a follow-up
after 1 year were analysed, and the impact on patients’
outcome was evaluated.
ICUs that were trained by the modified extended
method showed increased documentation rates of all
scores per patient and day. At 1-year follow-up, increased
scoring rates for all scores were maintained. Scoring rates
with training according to the local standard training
protocol did not increase significantly. Implementation of
delirium and pain monitoring were associated with a
decrease in mortality. Monitoring had no significant
influence on ventilation time or ICU length of stay. A
modified extended training strategy for ICU monitoring
tools leads to higher intermediate and long-term imple-
mentation rates, and is associated with improved patient
outcome. However, unmeasured confounders may have
biased these findings.
Exploring the cause of delirium, Girard et al. [15]
explored the associations of a priori-selected markers of
inflammation and coagulation with delirium during criti-
cal illness. In a prospective cohort study, blood from 138
mechanically ventilated medical ICU patients was col-
lected, and nine plasma markers of inflammation and
coagulation were measured. Daily delirium was assessed
using the Confusion Assessment Method for the ICU.
Among the patients studied, 78 % were delirious at some
point during the study. Two markers of inflammation and
one of coagulation were significantly associated with
delirium. After adjusting for covariates, lower plasma
concentrations of matrix metalloproteinase-9 (MMP-9)
and protein C were associated with increased probability
of delirium, and higher concentrations of soluble tumor
necrosis factor receptor-1 (sTNFR1) were associated with
increased probability of delirium. These results suggest
that specific aspects of inflammation and coagulation may
play a role in the evolution of delirium during critical
illness, and that these markers should be examined in
larger studies of ICU patients.
Nephrology
Several epidemiologic studies have clearly demonstrated
that mortality of critically ill patients is increased pro-
gressively with higher stages of acute kidney injury (AKI)
[16], even if renal replacement therapy is not required
[17]. A likely explanation for this may be the fact that
AKI is not a simple organ failure, but rather must be
considered a syndrome with extensive systemic conse-
quences. Significant impairment of other organs like the
lung, the heart or the brain has been demonstrated in
association with AKI. By demonstrating that increasing
stage of AKI is associated with decreased hepatic
metabolism of midazolam, most likely by influencing
CYP 3A activity even in the absence of overt signs of
hepatic dysfunction, Kirwan CJ and co-workers [18]
provide further support of the concept of systemic effects
of AKI. The study indicates that AKI may impair several
features of hepatic function, such as its detoxifying
capability, resulting in reduced hepatic drug metabolism
and consequently decreased drug clearance in patients
with AKI.
A quite common adverse effect of AKI is hyperkale-
mia, which is also among the five most frequent
indications to start renal replacement therapy [19].
However, as shown in an epidemiologic study on 39,705
patients from two tertiary care hospitals in Boston, USA,
even lower degrees of hyperkalemia on ICU admission
are associated with increased mortality [20]. In a multi-
variate analysis, the authors demonstrated a significantly
increased OR for mortality (1.25, 95 % CI 1.16–1.35,
p \ 0.0001) starting at slightly elevated potassium levels
of 4.5–5.0 mmol/l, and continuously increasing by every
0.5 mmol increment until an OR of 1.72 with potassium
levels [6.5 mmol/l (p \ 0.0001). The association
between increased mortality and high admission potas-
sium, however, appears to subside when hyperkalemia
resolves within 48 h, usually reflecting effective
treatment.
AKI is a frequent complication of liver failure.
Whereas the mechanism of AKI in the setting of chronic
liver failure is well known, the underlying pathophysiol-
ogy of AKI in the setting of acute liver failure (ALF),
developing in roughly 55 % of the patients, still needs to
be elucidated [21]. One possible pathogenetic factor may
be the renal toxicity of cadmium (Cd) released from the
liver in ALF. This was indicated by a study in 20 patients
with ALF [22] demonstrating a close association between
release of marker proteins of renal tubular injury (retinol
binding protein, a1-microglobulin, b2-mircroglobulin,
Clara cell protein-CC16) and increased urinary Cd
excretion, which could not be found in neurosurgical ICU
controls. For all other major trace elements determined,
only urinary copper excretion showed an association with
tubular injury markers.
Patients undergoing cardiovascular surgery are a fur-
ther cohort exhibiting a high risk of AKI, with average
incidence reported around 22 % and with dialysis
requirements around 2 % reported in large trials [23]. In
addition to the well known risk factors of age, heart
failure, diabetes, chronic kidney disease and hypertension,
an observational study including 1,182 patients with
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normal baseline renal function undergoing off-pump
coronary artery bypass surgery determined albumin levels
\4 g/dl as independent risk factor for postoperative AKI
(OR = 1.83), remaining highly significant even after
correction by a propensity score [24]. The findings of this
study substantiate a recent meta-analysis demonstrating
increased risk for AKI as well as mortality in hypoalb-
uminemic patients in both ICU and surgical settings [25].
Whether reduced serum albumin is just a diagnostic
marker for increased severity of disease or a derangement
whose correction by substituting human serum albumin
can improve outcome in critically ill patients will be
clarified by the soon to be published large EARSS and
ALBIOS trials.
In the intensive care unit, the role renal biopsy for
differential diagnosis of AKI is still somewhat contro-
versial. With only sporadic data available, most clinicians
withhold from doing this procedure in this setting because
of an unclear benefit to damage ratio. A large retrospec-
tive analysis of ten French intensive care units over a
period of 10 years showed that renal biopsy is a quite rare
diagnostic procedure performed at an average rate of
8.4/10,000 critically ill patients. Of note, complications of
this procedure were reported in nearly 25 % of the
patients undergoing this procedure; this is substantially
higher than the roughly 2 % reported for renal biopsies of
native kidneys in non-critically ill patients [26]. However,
when performed successfully, a diagnosis different from
acute tubular necrosis was found in up to 50 % of the
cases, indicating that, if used selectively, renal biopsy
may significantly improve diagnostic workup and result in
a relevant change of treatment.
Two publications addressed technical aspects of renal
replacement therapy. Filter survival is a major issue in
patients with enhanced bleeding risk preferably treated
without anticoagulation. The AN69ST membrane exhibits
enhanced heparin binding capacity, and was developed
for prolonging filter survival in anticoagulation free renal
replacement therapy. A single centre, randomized,
double-blind, crossover trial in 39 patients comparing
efficacy of this specific membrane against a standard
AN69 filter in circuits without anticoagulation could not
find any significant benefit with average filter survivals of
14.2 and 13.3 h, respectively [27]. An area of uncertainty
was the question whether continuous veno-venous
hemofiltration (CVVH) at a high dose does render hae-
modynamic measurements (e.g. CI, GEDVI, EVLWI)
based on unreliable thermodilution. This concern is
comprehensible, because it is well known that high dose
CVVH provides significant cooling to venous blood and
therefore may cause errors in measurements. The study by
Dufour et al. [28] finally proved reliability of haemody-
namic measurement using PiCCO2, even when high
volume hemofiltration using ultrafiltrate volumes up to
6 l/h was applied.
Epidemiology
The currently largest epidemiologic investigation of
patients with liver cirrhosis in the UK showed that a
gloomy prognosis ranging from 33 to 39 % has improved
only slightly for patients with liver cirrhosis over a period
of 13 years, as long as they do not suffer from other
additional organ failure [29]. In liver cirrhosis, patients
with sepsis requiring multiple organ support, mortality
reached 90 %. As described previously, APACHE II
score under-predicted mortality in cirrhotics. Conversely,
patients with chronic renal disease showing similar
characteristics and higher APACHE II score had mortality
rates nearly 50 % lower.
Demographic changes in industrialized countries
result in increased admission rates of old and very old
patients to ICUs. This perception is clearly underlined by
a study analysing 17,126 patients from 41 Austrian
intensive care units [30], showing a continuous increase
in the percentage of very old patients, defined by an age[
80 years, from 11.5 to 15.3 % over a 10-year period
(1998–2008). Associated with higher female life expec-
tancy, this age group is predominated by the female sex
with an average of 63 %. Despite the associated increase
in severity of illness, the authors found a decrease in
standardized mortality ratio (SMR). This finding supports
the concept that biological age alone is not a reliable
predictor of outcome and should not be used a major
selection criterion for admission. On the other hand, the
observed reduction of SMR in this study may result from
a bias occurring from change in the performance of
Simplified Acute Physiology Score (SAPS) II over time.
This problem was addressed in a study from the Nether-
lands [31] that included 12,143 patients, aged 80 and
above. The authors could nicely demonstrate that in the
setting of increasing average age, SAPS II scores requires
frequent recalibration to avoid down-trending of SMR
over time. The periodic introduction of new severity
scores, like the recent SAPS III score, is another possi-
bility to compensate for changes in case mix and
treatment modalities requiring frequent recalibration.
However, as shown by a prospective study in 103 Italian
ICUs, new scores may not necessarily perform superior to
older ones in specific populations [32]. Consequently,
potential requirement of regional customisations of new
severity of disease scores should be kept in mind.
Staffing and nursing workload are well known key
factors for patient outcome [33]. Consequently, validated
tools for quantifying nursing workload during in various
ICU conditions are desperately warranted. An interesting
step in that direction was undertaken by Debergh et al.
[34], who developed a score based on nursing activities.
By this approach, the authors could demonstrate and
quantify considerable variability of nursing workload,
based on case mix as well as time of the shift. This first
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step definitely requires further refinement and validation,
but represents an important development for planning
staffing requirements.
Sepsis, inflammation and biomarkers
This year, important contributions in the field of clinical
classification, diagnosis, biomarkers and treatment of
acute inflammatory conditions, including sepsis, were
published in Intensive Care Medicine. New pathogenetic
insights were published, as well as new consequences of
widely applied treatments, such as low-dose steroids,
transfusions and insulin.
The clinical classification of sepsis, severe sepsis, and
septic shock could differ according to the way the data are
recorded and interpreted. In their very clever and prag-
matic study, Klein Klouwenberg et al. [35] prospectively
audited a large tertiary intensive care unit over 22 months
to quantify the influence of minor variations in the fre-
quency, timing and method used to capture the data on the
diagnosis. For instance, the effects of the use of hourly
recorded data were compared with continuously recorded
data; the number of simultaneous criteria present and the
implication for diagnosis using different published sets of
criteria and other similar sets. The results are impressive:
the measured incidence of systemic inflammatory
response syndrome (SIRS) varied from 49 % (most
restrictive setting) to 99 % (most liberal setting). The
incidences of sepsis, severe sepsis and septic shock ran-
ged from 22 to 31 %, from 6 to 27 % and from 4 to 9 %
for the most restrictive versus the most liberal measure-
ment settings, respectively. In non-infected patients, 39 to
98 % of patients had SIRS. These observations very
clearly stress the importance of minor variations in the
definition of SIRS and mode of data recording on the
incidence of sepsis and also eligibility for clinical trials.
Similarly, the values of some physiological variables of
septic patients could differ during the nychthemeron, as a
result of the disruption of the circadian rhythm and of the
alterations of the hormonal response to the ambient light.
Verceles et al. [36] assessed the association between
ambient light and circadian melatonin release, measured
by urinary 6-sulfatoxymelatonin (6-SMT), in patients
with severe sepsis. In essence, they found no significant
differences among urinary 6-SMT levels across 4-h time
periods or between the 2 days, in spite of differences in
the light levels. These data support the disruption of cir-
cadian rhythm during severe sepsis.
In the field of biomarkers too, several important con-
tributions were published last year in Intensive Care
Medicine. The first of these important papers [37] reports
a close correlation between the levels of soluble trigger-
ing receptor expressed on myeloid cells (sTREM-1)
measured on samples of peritoneal fluid of patients with
acute pancreatitis. This biomarker was highly predictive
of an infection of the pancreatitis-associated necrosis. If
confirmed, these important findings will support the rou-
tine determination of fluid level of sTREM-1 for the
diagnosis of secondary infection of necrotic tissue in
patients with severe acute pancreatitis. Another major
daily challenge is the discrimination between bacterial
and non-bacterial infection. The degree of expression of
CD64 on the surface of neutrophils is believed to be a
promising approach to ascertain the presence of bacterial
sepsis. Gros et al. [38] measured the expression of CD64
expression by flow cytometry in blood samples drawn
from a cohort of consecutive patients with at least two
criteria for systemic inflammatory response syndrome and
admitted over a 7-month period. Approximately half of
the 293 patients had a confirmed bacterial infection.
However, the sensitivity of CD64 for the diagnosis of
bacterial infections was insufficient; this finding logically
implies the CD64 index may not be practically recom-
mended, although it may be useful in combination other
biomarkers.
In the field of sepsis, two different reports assessed the
prognostic accuracy of chromogranin A (CgA), a pro-
hormone released by the adrenal medulla upon stress. The
first of these two studies [39] aimed to examine the
prognostic significance of the admission value of vasost-
atin-1 (VS-I), the N-terminal peptide of CgA,
concentration in a population of 494 critically ill patients
and healthy controls. As expected, critically ill patients
had higher admission VS-I concentrations than controls;
the plasma VS-I concentration was lower in survivors
than in nonsurvivors, and lower in the absence than in the
presence of shock. Interestingly, admission VS-I and
lactate values were independent predictors of mortality.
The combination of both plus age provided a better
indication for predicting mortality than taking each alone
(p \ 0.01). Similarly, the CgA levels were measured at
the time of study inclusion and 72 h later in 232 patients
with severe sepsis recruited from 24 ICUs in Finland
(FINNSEPSIS study) [40]. Consistently, CgA levels at
inclusion and after 72 h correlated with several estab-
lished indices of risk in sepsis. Patients who died during
the hospitalization had higher baseline CgA levels than
hospital survivors. Prior cardiovascular disease or current
cardiovascular disorder were associated with higher CgA
levels after 72 h by linear regression. CgA levels on study
inclusion and after 72 h were independently associated
with hospital mortality by logistic regression. The prog-
nostic accuracy was comparable for CgA measurements
and SAPS II score, and the addition of CgA measure-
ments to the SAPS II score improved risk stratification of
the patients, as assessed by the category-free net reclas-
sification index. Taken together, the findings of these two
independent studies clearly confirm the accuracy of CgA
levels as predictor of poor outcome. Other biomarkers
were studied as well. For instance, Cribbs et al. [41]
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hypothesized that the circulating levels of endothelial
progenitor cells (EPC), a contributor to the vascular repair
following sepsis-related endothelial dysfunction, will be
inversely correlated with outcome during sepsis. They
indeed found that the patients with sepsis had significantly
lower mean endothelial progenitor cell colony counts
compared with controls, and they reported an inverse
correlation between EPC numbers and SOFA score, after
adjusting for mortality.
Steroids in sepsis
From a therapeutic standpoint, the effects of steroid
treatment yielded much attention this year: a first article
[42] reports the hormonal effects of low doses of steroids
given in a large landmark trial in which 299 septic shock
patients received a 7-day treatment with a combination of
hydrocortisone (50 mg intravenously four times daily)
and fludrocortisone (50 lg orally once daily) or matching
placebos. Overall, low-dose steroids induced both their
expected glucocorticoid and mineralocorticoid biological
effects and increased urine output. In contrast to these
findings supporting a beneficial role for low-dose steroids
during sepsis, the analysis of the database of the Surviv-
ing Sepsis Campaign (SSC), i.e. 27,836 adults with septic
shock, at 218 sites yielded different results [43]. A total of
17,847 patients in the database required vasopressor
therapy despite fluid resuscitation, and therefore met the
eligibility criteria for receiving low-dose steroids. A total
of 8,992 patients (50.4 %) received low-dose steroids for
their septic shock. Interestingly, patients in Europe and
South America were more likely to be prescribed low-
dose steroids compared to their counterparts in North
America. The adjusted hospital mortality was signifi-
cantly higher in patients who received low-dose steroids
compared to those who did not. There was still an asso-
ciation with increased adjusted hospital mortality with
low-dose steroids even if they were prescribed within 8 h.
These findings very clearly stress the need for frequent
reassessment of recommendations in relation with the
actual effect of any treatment, and in particular for widely
available drugs.
Blood transfusion in sepsis
Among other frequent treatments, the metabolic effects of
transfusion of red blood cell (RBC) in septic patients are
mostly unknown. Kopterides et al. [44] carefully moni-
tored the interstitial fluid concentrations of lactate,
pyruvate, glycerol and glucose before (T0) and after
transfusion of one to two RBC units. They found a
decreased the lactate-to-pyruvate (LP) ratio during and
after transfusion, which was unrelated to any of the pos-
sible confounders. These findings indicate that tissue
oxygenation is affected by RBC transfusion in critically
ill septic patients. Monitoring of tissue LP ratio by
microdialysis may represent a useful method for indi-
vidual clinical management.
Glycaemic control
Insulin therapy is also a common practice whose risks are
only partially known. Van Iersel et al. [45] sought to
identify risk factors for hypoglycaemia in neurocritical
care patients receiving intensive insulin therapy (IIT). In
this nested case–control study, the first hypoglycaemic
event of every patient (index moment) was used to match
to a control patient. Possible risk factors preceding the
index moment were scored using hospital records. Of 786
neurocritical care patients, 57 % developed hypoglycae-
mia. Independent risk factors for hypoglycaemia were
lowering nutrition without insulin dose reduction;
mechanical; lowering the dosage of norepinephrine; a
hyperglycaemic event; gastric residual in the 6 h pre-
ceding the index moment without insulin dose reduction;
and dosage of insulin at the index moment. The risk-to-
benefit of intensive insulin therapy requires such careful
assessment, especially in the neurocritical care setting.
In studies over tight glycaemic control, there is most
often a difference in blood glucose concentration and in
the amount of insulin given. It has not been possible to
directly link these results to a better outcome. On the
contrary, the total dose of insulin is most often a predictor
of an unfavourable outcome. Cappi et al. [46] reported
from a study where patients with severe sepsis and septic
shock (n = 63) were randomized to tight glucose control
or not. They observed that during the initial 72 h of ICU
stay, patients in the tight glucose control group had lower
free fatty acid levels as compared to controls. In the study,
it was also demonstrated, as has been reported before, that
a high free fatty acid level was associated with an unfa-
vourable outcome. The authors suggest free fatty acids
might be involved in a possible mechanism behind the
results of studies employing tight glycaemic control.
Nutrition and intestinal function
The connection often seen between parenteral nutrition
and an unfavourable outcome has often been suggested to
be linked to the fat emulsions used. Although the evi-
dence for this proposal has never been conclusive, many
centres limit their use of fat emulsions, in particular when
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triglyceridemia is present. As a part of metabolic moni-
toring of an unselected material of consecutive
admissions, Devaud et al. [47] observed that the most
common backgroud to hypertriglyceridemia was the use
of propofol sedation. Although the significance of
hypertriglyceridemia in terms of outcome is not well
characterised, the authors suggest that this observation
need to be more specifically elucidated.
It has long been recognised that gastrointestinal
function is an important predictor of outcomes. However,
gastrointestinal function is not a part of current scorings
for organ failures, or for the most commonly used scor-
ings to predict outcome at admission, such as APACHE II
or SAPS III. An important background factor for
neglecting the gastrointestinal tract is the absence of
definitions for gastrointestinal dysfunction. The Working
Group on Abdominal Problems (WGAP) within the
European Society of Intensive Care Medicine (ESICM)
has now put forward a suggestion of such a scoring [48].
They have reviewed the literature in the field and suggest
a scoring based on the success of enteral feeding. Four
grades were identified; from a self-limiting condition, to a
condition demanding intervention. The WGAP now sug-
gests that the grading be used in clinical studies, and it
eventually may be included organ failure scoring systems.
Finally, Peigne et al. [49] reported the causes and risk
factors of death in patients with thrombotic microangi-
opathies (TMA), drawn from the national French registry
and from a case–control analysis. The leading causes of
death were nosocomial infections, myocardial infarction,
stroke, and pulmonary embolism. Cases and controls did
not differ significantly regarding haemolysis parameters,
ADAMTS13 activity, or neurological or gastrointestinal
involvement. TMA was more frequently related to HIV or
cancer in patients who died. Compared to survivors, non-
survivors more often had cardiac involvement at diag-
nosis and less often received plasma exchange therapy.
Experimentals
Anti-inflammatory effects of anesthetic agent
Volatile anesthetics are known to attenuate inflammatory
response and tissue damage markers in acute organ injury
[50]. However, the mechanisms by which they exert the
anti-inflammatory effects remain unknown. Fortis et al.
[51] observed that anesthesia with sevoflurane suppresses
pulmonary inflammation and thus protects the lung from
the damage induced by intratracheal instillation of endo-
toxin followed by mechanical ventilation. The protective
effects of sevoflurane appear to be associated with its
agonistic effects at type-A gamma-aminobutyric acid
(GABAA) receptors in lung epithelial cells, exerting anti-
inflammatory properties.
Anesthesia in Pediatrics
Intrauterine growth restriction (IUGR) is one of the most
significant causes of perinatal morbidity and mortality,
and is associated with several neurodevelopmental dis-
orders [52]. These cerebral alterations enhance the
susceptibility to anesthesia-related neurodegenerative
consequences. Schubert and colleagues demonstrated that
the enhanced susceptibility to neurotoxicity induced by
anesthesia is not associated with adverse systemic or
organ-specific impairments, but may be related with
intrinsic apoptotic pathways [53]. These data should be
considered in clinical interventions in infants suffering
from fetal growth restriction.
Fluid resuscitation and acid–base equilibrium
impairment
Fluid resuscitation with normal saline has been frequently
used in critically ill patients, but may lead to metabolic
acidosis due to a reduction in the plasma strong ion dif-
ference (SID). Langer et al. [54] reported that in healthy
animals, at constant PCO2, the plasma pH can be pre-
dictably increased, decreased, or maintained unchanged,
according to the difference between the baseline plasma
and SID of the crystalloid solution infused. A better
understanding of these mechanisms may lead to a more
rational approach for the use of crystalloid solutions in
critically ill patients.
Mechanical ventilation and acute respiratory
distress syndrome
Although mechanical ventilation is a life-saving inter-
vention in patients suffering from respiratory failure,
prolonged mechanical ventilation is often associated with
numerous complications, including problematic weaning.
Current guidelines recommend that weaning from venti-
lator be achieved using a two-step strategy [55]; however,
there are controversies regarding the accuracy of the
various weaning predictors. Diaphragm electromyo-
graphic activity (EAdi)-derived indices obtained from a
neutrally adjusted ventilator assist (NAVA) catheter
during spontaneous breathing trial provide reliable pre-
dictors of weaning [56]. Nevertheless, the performance of
these indices is not better than the ratio of respiratory rate
to tidal volume.
The weakness of the inspiratory muscles, which plays
an important role in difficult weaning from mechanical
ventilation [57], is associated with changes within the
diaphragm muscle fibers [58]. Measuring contractile
function of muscle single fibers is the best technique to
study the involvement of contractile protein dysfunction,
since force-generating capacity of muscle fibers strongly
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depends on the content of the contractile protein. More-
over, for structural stability and optimal active force
generation, passive elastic structures are indispensable
[59]. In this line, titin is the major determinant of passive
elastic properties of striated muscles. Rats mechanically
ventilated for 18 h showed: (1) impaired diaphragm fiber
active force-generating capacity and passive force gen-
eration upon stretch; (2) loss of myosin, which contributes
to reduced active force generation; (3) reduced passive
force generation due to a decreased phosphorylation sta-
tus of titin; and (4) no discernible changes in the soleus
muscle [60].
Protective mechanical ventilation during acute
respiratory distress syndrome is associated with hyper-
capnic acidosis. Hypercapnic acidosis may lead to: (1)
pulmonary vasoconstriction [61], which contributes to
improvement of arterial oxygenation; and (2) vasodila-
tion in systemic circulation through increased
production of nitric oxide (NO) [62]. If, on the one
hand, hypercapnic acidosis increases NO production in
hypoxic lung regions attenuating hypoxic pulmonary
vasoconstriction (HPV), on the other hand, metabolic
acidosis augments HPV. In order to clarify this issue,
Nilsson and colleagues demonstrated that hypercapnic
acidosis does not potentiate HPV, but transiently
weakens it, without affecting endogenous pulmonary
NO production [63].
Pulmonary ischemia–reperfusion (IR) is associated
with a wide range of clinical events resulting in high
morbidity and mortality [64]. Microarray analysis repor-
ted that tyrosine phosphorylation (Src PTK) is an
important molecular mechanism related to acute inflam-
matory response. Blocking Src activation before ischemia
may represent a novel therapy to reduce pulmonary IR-
induced lung injury [65].
There are controversies regarding the beneficial
effects of negative pressure ventilation compared to
positive pressure ventilation [66]. Engelberts et al. [67]
tested the hypothesis that negative pressure exerts the
same pattern of lung distension as positive pressure when
the pressure–time and volume history profiles are identi-
cal and the application of negative pressure is over the
whole lung. They reported no differences in the effects of
positive versus negative pressure ventilation on lung
volumes and oxygenation.
The introduction of NAVA and measurements of
diaphragm electrical activity (EAdi) enable the quantifi-
cation of neural inspiratory drive [68]. So far, however,
there has been no information regarding the relative
contribution of the patient versus the ventilator to the
inspiratory tidal volume (VTinsp). Grasselli and col-
leagues [69] showed that VTinsp and EAdi can be used to
predict the contribution of the inspiratory muscles versus
that of the ventilator during NAVA, and thus quantify and
standardize the adjustment of the level of assist, reducing
the risk of excessive ventilator assist.
Positron emission tomography (PET) has been used to
monitor the inflammatory response in acute lung injury
(ALI), but its role in monitoring the fibroproliferative
phase of ALI has to be evaluated. At the late phase of
experimental ALI, a correlation was found between
fibrosis and high PET signal. Therefore, PET imaging is a
valid means of tracking both the inflammatory response
and fibrotic evolution of ALI [70].
There are several interesting studies examining the
impact of ventilatory settings in experimental acute
respiratory distress syndrome (ARDS) models implicated
with other underlying problems. Intra-abdominal hyper-
tension can induce a significant respiratory dysfunction,
and is associated with an increased risk of mortality in
critically ill patients [71]. Santos et al. [72] tested the
hypothesis that intra-abdominal hypertension contributes
to pulmonary inflammatory and fibrogenic responses in
ARDS, and mechanical ventilation at high tidal volume is
lung protective in extrapulmonary ARDS, but not in pri-
mary ARDS. Using a rat model of ARDS induced by
intratracheal or intraperitoneal injection of endotoxin, the
researchers showed that in the presence of intra-abdomi-
nal hypertension, mechanical ventilation at a tidal volume
of 10 mL/kg could limit atelectasis, and thus be beneficial
by decreasing lung elastance, lung apoptosis and the
production of cytokines in extrapulmonary ARDS.
However, mechanical ventilation at the same tidal volume
resulted in an increase in cytokine response when intra-
abdominal hypertension was present in primary ARDS. It
is noted that this conclusion was made based on a com-
plex animal model where the intra-abdominal
hypertension was set at a fixed level. Thus clinical rele-
vance of the study is yet to be evaluated. Retention of
CO2 during mechanical ventilation, in particular at low
tidal volume, may be problematic in certain clinical sit-
uations. Extracorporeal CO2 removal combined with low
tidal volume or low frequency positive pressure ventila-
tion has been shown to improve gas exchange in animals
and in humans [73]. However, a safety concern of long-
time application of CO2 removal devices remains. We-
arden et al. [74] conducted an experiment in awake and
standing sheep to examine the efficiency and safety of an
extracorporeal veno-venous CO2 removal system over a
chronic phase of 8 days. They reported that the device
Hemolung removed significant amounts of CO2 at low
blood flows with minimal adverse effects. Although the
results are promising, the role of the CO2 removal device
in ARDS conditions remains to be defined. Patients with
ARDS are at risk for dying not only from their critical
illness, but also from secondary processes such as noso-
comial infection. Ventilator associated pneumonia (VAP)
is the most common nosocomial infection in patients
receiving mechanical ventilation, despite many advances
in technology, antibiotic therapy and care of the patients
[75]. Zanella et al. [76] developed a very interesting
animal model to test the hypothesis that adequate tracheal
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orientation position can avoid aspiration of pathogens into
the lung. The investigators tested the specific hypothesis
that gravitational forces pull bacteria-laden secretions
from the oropharynx into the lungs in both supine and
semirecumbent position (i.e., tracheal tube is above hor-
izontal). On the contrary, if the trachea tube is kept below
horizontal, it will facilitate mucus clearance. The authors
demonstrated in a pig model that all animals kept with an
orientation of the trachea 45 above horizontal developed
VAP and respiratory failure, while none of the pigs kept
with an orientation of the trachea below horizontal
developed respiratory failure or infection, which was
likely a result of secretions being drained outward. This
study brings in an interesting concept in the future man-
agement of VAP.
A couple of excellent studies investigated the nonin-
vasive techniques to monitor chest wall tidal
displacement and tissue oxygenation. Mechanical venti-
lation can have important impact on lung compliance or
airway resistance, which in turn results in changes of the
dynamics of chest wall motion [77]. The study by Wa-
isman et al. [78], using a pneumothorax model in rabbits,
monitored the dynamics of chest wall motion, with the
attempt to identify the reasons for a delayed recognition
in the evolution of pneumothorax. Conventional moni-
toring methods of oxygenation and expired CO2 served as
gold standard. Interestingly, the investigators found that a
delay in diagnosis was due to a decrease in CO2 without
changes in SpO2, which was contrary to expectations.
This finding could well explain the phenomenon of
delayed diagnosis in the neonatal unit, where babies
sometimes experience small, progressing pneumothorax
that was misdiagnosed by CO2 readings. The study also
concluded that the use of motion sensors to measure chest
wall tidal displacements could indicate uneven ventilation
on the affected side. An obvious limitation of the study is
that the study was performed in healthy animals. Future
studies are required in animal models of lung injury and at
bedside in pediatric units. Early detection of oxygenation
failure is crucial to save life. Both macro- and micro-
circulatory transport of oxygen to tissues, causing regio-
nal hypoxia takes place in ARDS and sepsis [79]. It is a
very challenging issue for physicians to identify tissue
hypoxia, in particular local hypoxia, in a timely fashion.
Sensitive tools to detect the status of tissue oxygenation
are much appreciated at bedside. Dyson et al. [80] per-
formed an interesting study in a pig model, where tissue
hypoxia was induced by a variety of manipulations that
are important in critical care medicine. These manipula-
tions include changes in inspired oxygen fraction and
positive end-expiratory pressure, induction of haemor-
rhage and challenge of vasopressors and inotropic agents.
The investigators demonstrated that the monitoring of
bladder tissue oxygenation provided a sensitive indicator
of organ hypoxia compared to traditional global param-
eters during various cardiorespiratory challenges. This
study establishes some promising baseline observations
and offers a potentially useful tool for clinical monitoring
of tissue oxygen tension.
Pulmonary hypertension (PH) is the most serious
chronic disease of the pulmonary circulation but, so far,
has been poorly investigated in critically ill patients.
Lourenc¸o and colleagues evaluated the role of dual
endothelin-1 blocker (tezosentan) in an experimental
model of PH [81]. Intravenous administration of tezos-
entan attenuated pulmonary hypertension, reduced lung
inflammation and increased vasodilation. Therefore, when
the enteric route of administration is not tolerated or a
precise real time control of haemodynamics is required,
tezosentan seemed to be a good therapy for PH.
Cardiac arrest and ischemia reprefusion
Asphyxia is the primary cause of death in newborns and,
so far, there are no standard clinical treatments to protect
the immature newborn heart and intestine from hypoxia-
reoxygenation injury. However, an experimental study
showed that a single early intravenous cyclosporine bolus
following reoxygenation improved cardiac function and
mesenteric perfusion with attenuated myocardial and
intestinal damage [82]. Nevertheless, immediate treat-
ment may not be feasible for a large portion of newborns.
In this line, Gill et al. [83] compared both early and late
cyclosporine therapy in asphyxiated newborn piglets and
demonstrated that even though both therapies improved
cardiac recovery and myocardial oxygen transport, early
treatment offered superior cardio-protection and intestinal
injury attenuation.
Hydrogen sulfide (H2S) presents neuroprotective
effects, since it reduces both metabolism and temperature,
and may be a good therapeutic option for cardiac arrest.
Wei and colleagues [84] observed that inhalation of H2S
reduced neurohistopathological damage and improved
early neurological function after cardiac arrest and
resuscitation.
Vasopressin has been used in hypotensive shock in
adults [85], but its use remains limited in neonatal pop-
ulation. Dose–response effects of vasopressin on systemic
haemodynamics were evaluated, along with mesenteric
and cerebral perfusion in asphyxiated newborn piglets.
Vasopressin improved systemic haemodynamics without
compromising cardiac function, cerebral and mesenteric
haemodynamics in asphyxiated newborn piglets [86].
Inhalation of nitric oxide has been used for many years
for the treatment of ARDS and pulmonary hypertension
[87, 88]. It is believed that inhalation of NO may have
other pulmonary and extrapulmonary effects. In a case
report, inhalation of NO has been shown to be beneficial
in patients with acute right ventricular failure due to
myocardial infarction [89]. Neye et al. [90] hypothesized
that NO inhalation during the ischemic phase of acute
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myocardial infraction improves left ventricular function
and reduce infarct size. The investigators examined the
efficacy of inhaled NO during left anterior descending
coronary artery occlusion and subsequent reperfusion, in
comparison with nitrite or a soluble guanylate cyclase
inhibitor that were administered intravenously in rats. The
study showed that inhalation of NO during ischemia or
reperfusion improved left ventricular systolic function by
reducing myocardial infraction size and area-at-risk. The
protective effects of inhalation of NO and nitrite infusion
were blunted by the use of a soluble guanylate cyclase
inhibitor. The current study provides baseline observation
that inhalation NO may be protective against left ven-
tricular dysfunction during ischemia and reperfusion.
Further investigations are required to confirm the findings
and to understand the mechanisms involved.
Sepsis
Patients suffering from sepsis are frequently implicated
with acute kidney injury. The primary resuscitation
strategy for these patients is fluid replacement aiming to
improve organ perfusion and oxygenation [91]. In animal
models of sepsis, it has been reported that LPS-induced
endotoxemia is associated with renal hypoperfusion,
microvascular hypoxia and systemic inflammatory
response [92]. Vasoconstrictors are thus commonly used
in the treatment, but their effects on bioenergetics remain
largely unknown. A study by May et al. [93] tested the
hypothesis that the infusion of a vasoconstrictor would
have a deleterious effect in renal blood flow and bioen-
ergetics during early gram-negative sepsis. The authors
employed a model of hyperdynamic sepsis in a large
mammal of sheep to closely mimic human disease. It is
interesting to notice that the intravenous administration of
angiotensin II restored blood pressure, but further reduced
renal blood flow in the septic model. However, no change
in renal ATP was observed. The authors concluded that
during early hypotensive endotoxemia, there was no
evidence of renal bioenergetic failure despite decreased
renal blood flow, and that the treatment with the powerful
renal vasoconstrictor angiotensin II did not lead to dete-
rioration in renal bioenergetics. The results are
encouraging with respect to the kidney concern when
vasoconstrictors are administered during sepsis, but fur-
ther studies are required to examine the effects of
different vasoconstrictors on renal bioenergetics in rela-
tion to organ function and tissue repair. In sepsis, tissue
repair mechanisms may be impaired.
Sepsis is the leading cause of death in critically ill
patients, and is associated with uncontrolled and exces-
sive cytokine/chemokine release [94]. However, the
therapeutic intervention target on cytokines has failed to
reduce mortality, suggesting the molecular complexity
within the inflammatory response. In order to better
understand the pathogenesis of sepsis, Finney et al. [95]
investigated the cytokine/chemokine release in response
to lipopolysaccharide (LPS) or lipoteichoic acid (LTA),
which is a cell wall component of Gram-positive bacteria
and the functional equivalent to LPS in Gram-negative
bacteria. At clinically relevant concentrations, LPS and
LTA induced different cytokine/chemokine release, in
accordance with clinical studies comparing Gram-positive
and Gram-negative infections [96]. These data suggest the
importance of understanding the nature of cytokine reg-
ulation between Gram-positive and Gram-negative
bacteria for the future treatment of sepsis.
The mechanisms behind the effects of temperature on
central nervous system (CNS) require elucidation.
Hypothermia reduces while hyperthermia increases the
early activation of nuclear factor (NF)-kB and the sub-
sequent production of tumor necrosis factor (TNF)-a,
interleukin (IL)-10, and nitric oxide. In this line, tem-
perature dependent changes in microglial TNF-a
production during the early phase and interleukin (IL)-10
and nitric oxide production during the late phase indicate
that these factors could be useful as clinical markers to
monitor hypothermia-related neuronal protection and
hyperthermia.
The activation of innate immune cells is critical for
appropriate control of invading microorganisms. In sep-
sis, the hyperresponsiveness may lead to production of
an excess of proinflammatory mediators and conse-
quently, multiple organ failure [97]. Myeloid-derived
suppressor cells (MDSC), a heterogeneous population of
cells, present immunomodulatory effects and have been
studied in cancer, inflammation, and infection. Derive
and colleagues showed a protective effect of MDSC in
sepsis and suggested the development of pharmacologi-
cal agents known to promote the expansion of MDSCs
[98].
The accumulation of apoptotic cells can release toxic
and proinflammatory mediators that lead to tissue dam-
age. Milk fat globule-EGF factor VIII (MFG-E8), mainly
produced by macrophages and dendritic cells, is an
opsonin for apoptotic cells and acts as a bridging protein
between apoptotic cells and phagocytes [99]. A study by
Shah et al. [100] showed that the treatment with recom-
binant human (rh) MFG-E8 protein reduced organ
damage in liver and kidney that was associated with an
attenuated systemic inflammatory response in a rodent
model of sepsis induced by cecal ligation and puncture.
The protective effects of MFG-E8 appeared to be in a
dose-dependent manner. However, there are many unan-
swered questions in the study: How does the rhMFG-E8
protein act on cells and organ systems? When is the MFG-
E8 administered? What is the frequency of the drug
delivery? The answers to these questions will justify the
use of MFG-E8 in sepsis.
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